PubMed Koren MA, , Lin L, Eckels KH, De La Barrera R, Dussupt V, Donofrio G, Sondergaard厄尔, Mills KT, Robb ML, Lee C, Adedeji O, Keiser P, Curley J, Copeland N, Crowell T, Hutter J, Hamer M, Valencia-Ruiz一, Darden J, Peel S, Amare M, Mebrahtu T, Costanzo M, Krebs SJ, Gromowski G, Jarman RG, Thomas SJ, Michael NL, Modjarrad K. 纯化灭活寨卡病毒候选疫苗在美国接种日本脑炎病毒或黄热病病毒疫苗的成人中的安全性和免疫原性:1期研究, randomized, double-blind, 安慰剂对照临床试验. 2023
PubMed Lin L,, Koren MA, Paolino KM, Eckels KH, De La Barrera R, Friberg H, Currier JR, Gromowski GD, Aronson NE, Keiser PB, Sklar MJ, Sondergaard厄尔, Jasper LE, Endy TP, Jarman RG, Thomas SJ. 2021年一项I期随机临床试验中采用异源启动-增强策略的登革热减毒活疫苗的免疫原性
PubMed Lima NS,, Moon D, Darko S, De La Barrera RA, Lin L, Koren MA, Jarman RG, Eckels KH, Thomas SJ, Michael NL, Modjarrad K, Douek DC, Trautmann L. 对日本脑炎病毒的预先免疫改变CD4 T细胞对寨卡病毒灭活疫苗的反应
PubMed Lin L,, Koren M, Jarman RG, Eckels KH, Lepine E, McArthur MA, Currier JR, Friberg H, Moris P, Keiser PB, De La Barrera R, Vaughn DW, Paris RM, Thomas SJ, Schmidt AC. as03b佐剂灭活四价登革热病毒疫苗不同接种时间的安全性和免疫原性.S. 成人:2020年1/2期随机研究
PubMed Diaz C,, Koren M, Lin L, Martinez LJ, Eckels KH, Campos M, Jarman RG, De La Barrera R, Lepine E, Febo I, Vaughn DW, Wilson TM, Paris RM, Schmidt AC, Thomas SJ. 波多黎各健康成人不同配方登革热纯化灭活疫苗的安全性和免疫原性:随机随访3年后的最终结果, 2020年安慰剂对照I期研究
PubMed Dussupt V,, Sankhala RS, Gromowski GD, Donofrio G, De La Barrera RA, Larocca RA, Zaky W, Mendez-Rivera L, Choe M, Davidson E, McCracken MK, Brien JD, Abbink P, Bai H, Bryan AL, Bias CH, Berry IM, Botero N, Cook T, Doria-Rose NA, Escuer AGI, Frimpong JA, Geretz A, Hernandez M, Hollidge BS, Jian N, Kabra K, Leggat DJ, Liu J, Pinto AK, Rutvisuttinunt W, Setliff I, Tran U, Townsley S, Doranz BJ, Rolland M, McDermott AB, Georgiev IS, Thomas R, Robb ML, Eckels KH, Barranco E, Koren M, Smith DR, Jarman RG, George SL, Stephenson KE, Barouch DH, Modjarrad K, Michael NL, Joyce MG, Krebs SJ. 在经历过登革热的供体中接种寨卡疫苗诱导的强效寨卡和登革热交叉中和抗体2020